Regeneron Class Action Lawsuit: The Settlement Process in Securities Litigation

Introduction to the Regeneron Class Action Lawsuit

• The Regeneron class action lawsuit seeks to represent purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) common stock between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”).

• Captioned Cheatham v. Regeneron Pharmaceuticals, Inc., No. 26-cv-06026 (S.D.N.Y.), the Regeneron class action lawsuit charges Regeneron and certain of Regeneron’s top executives with violations of the Securities Exchange Act of 1934.

• If you suffered substantial losses and wish to serve as lead plaintiff of the Regeneron class action lawsuit or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].

• Lead plaintiff motions for the Regeneron class action lawsuit must be filed with the court no later than September 8, 2026.

Three Step Settlement Process

Settlement Negotiation Stages and Mediation

• Settlement negotiations in securities litigation typically occur through structured processes involving multiple stages. Initial discussions often begin informally between counsel, with parties exchanging preliminary damage estimates and evaluating the strengths and weaknesses of their respective positions.

• Formal mediation frequently facilitates productive settlement discussions, with experienced mediators helping parties navigate complex legal and factual issues. Mediators in securities cases often possess specialized expertise in financial markets and securities law, enabling them to understand the nuances of complex fraud allegations and damage calculations.

• The negotiation process typically involves extensive analysis of potential damages, including market-based loss calculations and expert economic testimony. Parties must consider various factors, including the likelihood of prevailing at trial, potential damage awards, and the costs and risks of continued litigation.

• Multi-stage negotiations often occur, with initial discussions focusing on liability issues and later stages addressing specific settlement amounts and terms. The complexity of securities cases frequently requires multiple mediation sessions and extensive document exchange before reaching final agreements.

Court Approval and Fairness Hearings

• Court approval represents a mandatory requirement for all securities class action settlements. Federal courts must determine that proposed settlements are “fair, reasonable, and adequate” before granting final approval. This process protects class members who are not directly involved in settlement negotiations.

• Fairness hearings provide opportunities for class members to voice objections to proposed settlements and for courts to evaluate the adequacy of the recovery. These hearings typically involve testimony from lead plaintiffs, counsel, and expert witnesses regarding the settlement’s fairness and the reasonableness of attorney fees.

• The court approval process includes preliminary approval, where courts authorize class notification, and final approval following the fairness hearing. During this period, class members may object to the settlement or opt out of the class to pursue individual claims.

• Judicial scrutiny of settlements has intensified in recent years, with courts requiring more detailed justifications for settlement amounts and fee arrangements. This enhanced oversight helps ensure that settlements provide meaningful compensation to injured investors while preventing excessive attorney fees.

Common Fund Distribution and Proof of Claims

Common fund principles govern the distribution of settlement proceeds in securities class actions. These funds are created through litigation efforts and distributed to class members based on their proportionate losses during the relevant time period.

The proof of claims process requires eligible class members to submit documentation demonstrating their securities transactions and resulting losses. Claims administrators review submissions and calculate individual recovery amounts based on court-approved distribution plans.

Distribution methodologies typically employ “first-in, first-out” (FIFO) or other recognized approaches to allocate settlement funds among class members. These methodologies must be approved by the court and provide fair compensation based on demonstrable losses.

Recovery rates in securities settlements vary significantly based on factors including settlement size, number of claimants, and distribution methodology. Recent studies indicate that recovery rates typically range from 2-10% of investor losses, though some cases achieve higher recovery percentages.

Here’s a breakdown of what influences those rates:

• Average Settlement Amount:  In 2025, was $40.6, a decrease of 7% from 2024, which was a reflectment of mega-settlements which also slightly decreased from previous years.

• Settlement size. The size of the settlement is a major factor. In 2024, the median settlement amount increased to $17 million, the largest since 1007..

• Number of claims submitted. The number of claims filed by eligible investors can dramatically impact the final payout percentage for those who do submit a claim. If only a small fraction of eligible investors file, the recovery percentage for those who do can be substantially higher. For example, after the “Dieselgate” scandal, Volkswagen’s $48 million settlement resulted in nearly 200% recovery for the small percentage of investors who successfully filed a claim.

• Distribution methodology and claim rejection. The methodology for distributing settlement funds and the rate of rejected claims can further reduce the final payout. The Volkswagen case, for example, had a high rejection rate, contributing to the higher payout for successful claimants.

• Lead plaintiff involvement. Historically, institutional investors serving as lead plaintiffs have been associated with cases that result in larger settlements. When institutional involvement decreases, as it did in 2024, it can correspond with lower median damages.

• Type of claim and timing. The type of legal claim and the case’s complexity also play a role. For instance, Securities Act of 1933 claims and cases with accompanying derivative actions can have different settlement characteristics. The stage at which the case settles (e.g., before or after class certification) can also be a factor.